US20190355082A1 - Use of web-based symptom checker data to predict incidence of a disease or disorder - Google Patents
Use of web-based symptom checker data to predict incidence of a disease or disorder Download PDFInfo
- Publication number
- US20190355082A1 US20190355082A1 US16/523,238 US201916523238A US2019355082A1 US 20190355082 A1 US20190355082 A1 US 20190355082A1 US 201916523238 A US201916523238 A US 201916523238A US 2019355082 A1 US2019355082 A1 US 2019355082A1
- Authority
- US
- United States
- Prior art keywords
- illness
- symptom
- incidence
- server computer
- datasets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16877—Adjusting flow; Devices for setting a flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/002—Packages specially adapted therefor ; catheter kit packages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/08—Tubes; Storage means specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M39/28—Clamping means for squeezing flexible tubes, e.g. roller clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1413—Modular systems comprising interconnecting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16877—Adjusting flow; Devices for setting a flow rate
- A61M5/16881—Regulating valves
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/04—Forecasting or optimisation specially adapted for administrative or management purposes, e.g. linear programming or "cutting stock problem"
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/08—Tubes; Storage means specially adapted therefor
- A61M2039/082—Multi-lumen tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/1456—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/162—Needle sets, i.e. connections by puncture between reservoir and tube ; Connections between reservoir and tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16813—Flow controllers by controlling the degree of opening of the flow line
Definitions
- the present disclosure relates to systems and methods for the early detection and characterization of outbreaks of infectious diseases or disorders.
- the system may be used for capturing and analyzing web-based patient symptom queries to thereby predict future changes in the incidence of infectious illness in both time and location. Methods to predict the incidence of disease or disorders are also disclosed.
- search engines such as Google and Yahoo.
- the Internet more specifically social media, is growing as a resource to gain advice or chat about health conditions.
- Microblogging sites like Twitter and Facebook or search engines such as Google collect random entries about conditions affecting its users.
- the best developed active surveillance system on the national scale is the CDC's system for influenza. It provides a clear picture of the emergence and development of the annual influenza epidemic, but its reports lag the actual changes in influenza incidence by about a week. The reason for the lag is that the system depends on the reporting of medical visits by specific sentinel medical practices, of individuals ill with symptoms compatible with influenza. It requires that individuals become ill enough to request an appointment and wait for that appointment to occur before there is the possibility of a report being generated.
- a system for predicting the incidence of a disease or disorder includes a web-based symptom checker for producing a structured dataset, a data analysis component for producing a multivariate dataset from the structured dataset, a principle component analysis component for producing a linear combination of orthogonal symbols representative of a disease or disorder, and a multivariate statistical model for predicting the incidence of disease or disorder using the symbols constructed from the principal component analysis.
- a method for predicting the incidence of a disease or disorder includes producing a multivariate dataset representing internet symptom counts, performing principle component analysis on the multivariate dataset, creating a time series model using weekly illness incidence data and principal components of internet symptom data, and applying the time series model to new internet symptom data to predict the incidence of a disease or disorder.
- FIG. 1 is an overview diagram of a system for predicting the incidence of a disease or disorder according to a first exemplary embodiment
- FIG. 2 is a block flow diagram for a system for predicting the incidence of influenza like illness (ILI) according to a second exemplary embodiment
- FIG. 3 is a method for predicting the incidence of a disease or disorder
- FIG. 4 is an overview diagram of structured web-based symptom checker dataset
- FIG. 5 is a diagram of Health and Human Services (HSS) Regions
- FIG. 6 is a graph of CDC (Center of Disease Control) ILI Data for the 2009-2010 flu season for HSS Regions 3, 4, 5, and national;
- FIG. 7 is a timeline illustration of the time series modeling approach used in the system and methods of FIGS. 1-3 ;
- FIG. 8 is a block flow diagram for a system for predicting the incidence of disease or disorder according to a third exemplary embodiment
- FIG. 9 is a method for predicting the incidence of a disease or disorder according to a second exemplary embodiment
- FIG. 10 is a table of principal component analysis (PCA) parameter estimates indicating the most statistically significant predictor components (PCs) for predicting CDC ILI counts using the system according to the second exemplary embodiment shown in FIG. 2 ;
- PCA principal component analysis
- FIG. 11 is a graph of the prediction performance of the system according to the second exemplary embodiment shown in FIG. 2 in HHS Region 3;
- FIG. 12 is a graph of the prediction validation of the system according to the second exemplary embodiment shown in FIG. 2 in HHS Region 4;
- FIG. 13 is a graph of the prediction validation of the system according to the second exemplary embodiment shown in FIG. 2 in HHS Region 5;
- Prediction systems for detecting the incidence of a disease or disorder may capture patient-based symptom queries to a public symptom search engine in its clinician-informed database of disease symptoms. This database may then be analyzed at or near real-time to detect changes in the incidence of inquiries related to infectious illness syndromes in terms of both time and location. At the end of the development process, the prediction system may be validated against real outbreak data in order to demonstrate its real-world performance.
- the systems and methods according to the following disclosure may include: 1) Evaluation of events in (near) real-time; 2) The ability to discriminate meaningful information from background noise with adequate sensitivity to provide useful early detection and; 3) The ability to provide geographical and temporal characteristics of an event (i.e., where it is centered, the likely extent, speed of spread, and the characteristics of illness that indicate specific causes).
- any major public system based on Internet usage has a limited window of maximum utility, which occurs very early and very briefly in an event.
- the parameters of public interaction change, and affect the ability of any analytic system based on evaluating internet data to reach reliable assessments of the important characteristics of the outbreak. It is precisely this early and limited window of patient queries that will allow a predictive system to accurately and reliably provide early warning and detection of an outbreak.
- the disclosed systems and methods may utilize a stronger dataset (e.g.
- data from OLSC-DT can be structured data already filtered to health-related data (rather than the world of search queries provided by Google) and because geo-location (using both IP and user-inputted zip codes) and time tags can be collected by OLSC-DT, predictive systems and methods using this dataset are expected to provide greater reliability in detection as compared with data mined from unstructured sources.
- a system 100 for predicting the incidence of a disease or disorder includes at least one third party side and a supervisor side.
- the number of third party sides depends on the number of users reporting symptoms of a disease or disorder to the symptom checker website.
- a third party user 104 i.e., a person experiencing symptoms of illness and utilizing the symptoms checker website
- inputs data into a third party user terminal 102 e.g. a computer, tablet computer, or other device running a web browser connected with the symptoms checker website, although other terminal devices such as a dedicated “dumb” terminal are also contemplated).
- the user 104 views a display 106 attached to the terminal 102 so that a web-based symptom checker website 108 may be engaged by the user 104 .
- the user 104 inputs symptom specific data into the website 108 using a dialog, preferably a graphical user interface (GUI) dialog, such as a web form presenting lists of symptoms and checkboxes via which the user identifies the symptoms present in the user.
- GUI graphical user interface
- Some symptoms may be entered using other GUI dialogs which enable entry of quantitative data, e.g. body temperature as measured by an oral thermometer, body weight, et cetera.
- Other GUI dialogs are also contemplated.
- the resulting data are organized as a structured data set for the user 104 .
- the specific user-symptom association is not maintained, but rather the data for the purpose of disease tracking are output as a structured symptom dataset 112 containing individual user 104 symptom counts, each symptom count associated with a time stamp and geographical designation.
- This approach loses relevant information pertaining to co-occurrence of symptoms in a single user; however, it has advantages in enhanced data processing efficiency, reduced data storage requirements, and elimination of certain potential medical information privacy issues.
- the structured dataset 112 may include demographic information, such as the age, gender, and zip code of the user 104 . It may also include specific symptoms selected by the user 104 , body location, qualifiers or follow-up questions to symptoms, or possible conditions based on algorithms using symptom qualifiers.
- the structured dataset 112 is uploaded to a SQL symptom database 114 and stored on a server 130 .
- a supervisor 124 inputs data into a predictive model terminal 122 .
- the supervisor views a display 126 attached to the terminal 122 so that an analysis/prediction interface 128 may be engaged by the supervisor 124 .
- the input provided by the supervisor 124 at the predictive model terminal 122 includes select database queries or other filters for creating subsets of data within a server 130 using data from the SQL symptom database 114 .
- the input may also include a time series lag setting, which is utilized by the server 130 in creating time series models.
- the server 130 includes an input/output module 132 which receives input from the third party user terminal 102 and predictive model terminal 122 , as well as past weekly (or other chosen time interval) illness incidence data 157 and new symptom incidence data 159 .
- the illness incidence data 157 may be obtained by any reporter agency or sentinel provider that collects counts of symptom incidents associated with a disease or disorder. For example, in the United States the Centers for Disease Control (CDC) collects data associated with influence like illness (ILI). The CDC defines ILI by the symptoms of fever (equal to or greater than 100°) and cough and/or sore throat. The CDC collects its data from sentinel providers across the country.
- CDC Centers for Disease Control
- the exemplary server computer 130 may include main memory 140 which stores instructions 141 for implementing the exemplary method described with respect to FIG. 3 , and a processor 134 , in communication with the memory 140 , for executing the instructions 141 .
- Hardware components 132 , 134 , 140 , and 150 may communicate via a data/control bus 136 .
- the main memory 140 stores a dataset analysis component 142 for creating a multivariable dataset from data within the SQL symptom database 114 .
- a dataset filtering component 144 creates subsets within the multivariable dataset based on, e.g., physician advice as to the most important symptoms, or other inputs provided by the supervisor 124 at the predictive model terminal 122 .
- feature selection may be “front-ended”, e.g. performed during construction of the structured symptom data set 112 by only storing the chosen subset of symptoms as the data set 112 ).
- a PCA component 146 performs principal component analysis (PCA) on the subsets (or filtered multivariable dataset) to produce a linear combination of orthogonal variables. Other methods are contemplated for the construction of feature vectors from the structured symptom data set.
- a time series modeling component 148 creates a time series model. The time series model may be dependent upon the output of the PCA component 146 and weekly illness incidence data 157 .
- the exemplary server 130 also includes a data memory 150 which stores the most current time series model 152 calculated by the time series modeling component 152 .
- the current time series model 152 is stored in data memory 150 to predict the incidence of new disease or disorder occurrences in a designated future (e.g. week-ahead) time interval based on the time series model 152 applied to new symptom incidence data 159 and historic weekly incidence data 157 .
- the server computer memory 140 , 150 may be separate or combined and may represent any type of non-transitory computer readable medium such as random access memory (RAM), read only memory (ROM), magnetic disk or tape, optical disk, flash memory, or holographic memory.
- the memory 140 , 150 comprises a combination of random access memory and read only memory.
- the processor 134 and memory 140 and/or 150 may be combined in a single chip.
- the input/output module 132 allows the computer to communicate with other devices via a computer network, such as a local area network (LAN) or wide area network (WAN), or the Internet, and may comprise a modulator/demodulator (MODEM), wired Ethernet, wireless WiFi, or so forth.
- LAN local area network
- WAN wide area network
- MIMO modulator/demodulator
- the digital processor 134 can be variously embodied, such as by a single-core processor, a dual-core processor (or more generally by a multiple-core processor), a digital processor and cooperating math coprocessor, a digital controller, or the like.
- the digital processor 134 in addition to controlling the operation of the server computer 130 , executes instructions 141 stored in memory 140 for performing the method outlined in FIG. 3 .
- the third party user terminal 102 and predictive model terminal 122 may be similarly configured to the server computer 130 and may each comprise one or more specific or general purpose computing devices, such as a PC, such as a desktop, a laptop, palmtop computer, portable digital assistant (PDA), server computer, cellular telephone, tablet computer, pager, combination thereof, or other computing device capable of executing instructions for performing the client side operations of the exemplary method.
- the third party user terminal 102 and predictive model terminal 122 may have memory, a processor, and an input/output device for communicating with other devices via the network.
- the third party user terminal 102 and predictive model terminal 122 may also include an agent user input device, analogous to user input device, such as a keyboard, keypad, touchscreen, cursor control device, or combination thereof, or the like, for inputting commands to the respective processor.
- the term “software,” as used herein, is intended to encompass any collection or set of instructions executable by a computer or other digital system so as to configure the computer or other digital system to perform the task that is the intent of the software.
- the term “software” as used herein is intended to encompass such instructions stored in storage medium such as RAM, a hard disk, optical disk, or so forth, and is also intended to encompass so-called “firmware” that is software stored on a ROM or so forth.
- Such software may be organized in various ways, and may include software components organized as libraries, Internet-based programs stored on a remote server or so forth, source code, interpretive code, object code, directly executable code, and so forth. It is contemplated that the software may invoke system-level code or calls to other software residing on a server or other location to perform certain functions.
- a system 200 for predicting the incidence of a disease or disorder suitably implemented using hardware uses OLSC-DT data 212 .
- the OLSC-DT data has substantial advantages for disease occurrence tracking because users input their symptoms using a web form or other dialog specifically configured to elicit symptom information, obviating the need for text interpretation or other data mining operations, and decreasing the number of misleading queries.
- Many of these systems, such as WebMD's Symptom Checker are tied to health information services, which provide users with additional information on medical conditions and topics.
- These systems maintain customized portal, which walk users through a series of questions answered through the click of a button or selection from drop-down lists about the body location and specific symptoms with qualifying information such as intensity or character of pain. Based on the information entered, the user is directed to seek emergency care and/or shown a list of possible causes.
- Some of these systems like the WebMD Symptom Checker, also collect additional parameters, such as gender, age, date, time, and geographical locations through zip code entry and user internet protocol (IP) address. Analysis of these data, which specifically utilizes queried symptoms, can look at changes in the incidence and frequencies of symptom queries and trends over time, and by location, for various conditions to determine if there are potential spikes in illnesses or disease conditions.
- IP internet protocol
- Preparation of the system 200 includes the OLSC-DT data 212 being imported to a SQL database 214 .
- the data 212 is then selected and counted by unique visitors by symptom and region by dataset analysis component 242 .
- a region-specific weekly counts of symptom incidence multivariable data set 243 is produced.
- the dataset 243 is filtered into one or more subsets defined by subject matter expertise (SME, e.g. influenza-relevant symptoms identified by medical experts) by a dataset filtering component 244 .
- SME subject matter expertise
- 14 subsets are used representing 14 important symptoms for influenza like illness (ILI).
- Development of the system 200 includes the filtered dataset being used for principal component analysis (PCA) by a PCA component 246 .
- PCA principal component analysis
- Other feature construction methods such as partial lease squares regression, are contemplated for constructing feature vectors.
- the output of the PCA component 246 may subsequently be used along with weekly CDC ILI Incidence data 247 by a time series model component 248 to produce a time series model 248 .
- the second exemplary embodiment system 200 differs from system 100 in that weekly illness incidence data is specifically obtained from the CDC and the symptom query data is subset to include only symptoms involved in influenza like illness (ILI).
- ILI influenza like illness
- Application of the predictive system 200 includes applying the time series model 248 to new specific weekly counts of symptoms incidence 259 to create a future prediction of ILI incidence 260 .
- a method for predicting the incidence of a disease or disorder starts at S 101 .
- a dataset is uploaded into a SQL database.
- queries are generated to summarize-out patient symptom counts from visitors that queried individual symptoms.
- a multivariate dataset is produced representing patient symptom counts, time of queries, and/or geography, which may or may not include originating I.P. address.
- the multivariate dataset is subset based on, e.g. algorithms, manually input filters, expert medical device regarding the important predictive factors associated with the particular disease being predicted, ect.
- a principal component analysis or other multivariate feature construction algorithm is performed to create orthogonal variables that are linear combinations of input variables.
- a time series model is created using weekly illness incidence data.
- the time step lag in a time series model is adjusted based on the desired scope of prediction.
- the time series model is applied to new region specific data showing incidence of a disease or disorder to predict the incidence of a new disease or disorder.
- the method of FIG. 3 may be implemented on one or more general purpose computers, special purpose computer(s), a programmed microprocessor or microcontroller and peripheral integrated circuit elements, an ASIC or other integrated circuit, a digital signal processor, a hardwired electronic or logic circuit such as a discrete element circuit, a programmable logic device such as a PLD, PLA, FPGA, Graphical card CPU (GPU), or PAL, or the like, e.g. on the hardware described with reference to FIG. 1 .
- the method illustrated in FIG. 3 may be implemented in a computer program product or products that may be executed on a computer.
- the computer program product may be a non-transitory computer-readable recoding medium on which a control program is recorded, such as a disk, hard drive, or the like configured for performing the method.
- a control program such as a disk, hard drive, or the like configured for performing the method.
- Common forms of computer-readable media include, for example, floppy discs, flexible discs, hard disks, magnetic tape, or any other magnetic storage medium, CD-ROM, DVD, or any other optical medium, a RAM, a PROM, an EPROM, a FLASH-EPROM, or other memory chip or cartridge, or any other non-transitory medium from which a computer can read and use.
- the computer program product may be integral with the server computer 130 , (for example, an internal hard drive of RAM), or may be separate (for example, an external hard drive operatively connected with the server computer 130 ), or may be separate and accessed via a digital data network such as a local area network (LAN) or the Internet (for example, as a redundant array of inexpensive of independent disks (RAID) or other network server storage that is indirectly accessed by the server computer 130 , via a digital network).
- LAN local area network
- RAID redundant array of inexpensive of independent disks
- the method may be implemented in transitory media as a transmittable carrier wave in which the control program is embodied as a data signal using transmission media, such as acoustic or light waves, such as those generated during radio wave and infrared communications, and the like.
- transmission media such as acoustic or light waves, such as those generated during radio wave and infrared communications, and the like.
- a structured dataset such as that collected by WebMD Symptom checker categorizes data into numerous categorizes, such as Query Information, Symptoms, Body Locations and Qualifers, and Conditions.
- a variable number of symptoms may be associated with each query; a variable number of body locations and qualifiers may be associated with each symptom; a variable number of conditions may be associated with each query.
- a structured dataset such as the dataset described in FIG. 4 is uploaded to a SQL server for further refinement by generated queries. Queries may reduce the dataset to, e.g., a specific number of predictive symptoms.
- weekly illness incidence data may be obtained from any reporter agency or sentinel provider that collects counts of symptom incidents associated with a disease or disorder.
- CDC ILI Data is used.
- the CDC collects data associated with influence like illness (ILI) data from sentinel providers across the country and reports it according to regions defined by the Health and Human Services (HHS).
- HHS Health and Human Services
- the CDC specifically defines ILI by the symptoms of fever (equal to or greater than 100°) and cough and/or sore throat. Any number of HHS regions may be used in creating the time series model.
- region 3 corresponds to Delaware, District of Columbia, Md., Pennsylvania, Virginia, and West Virginia.
- Region 4 corresponds to Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee.
- Region 5 corresponds to Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin.
- a time series modeling approach includes modeling of differences to achieve near stationarity of time series data.
- Lagged differences of CDC ILI Count data such as that represented in FIGS. 5-6 , are used in a time series modeling approach (Z variables with subscripts t- 3 and t- 4 ) in the equations illustrated in FIG. 7 .
- Symptom query features such as those constructed by principal component analysis are used in the modeling approach (X variables with subscript t- 2 ) in the equations illustrated in FIG. 7 .
- CDC ILI counts may be predicted up to two weeks ahead (represented by t, week predicted) according to the time series modeling approach. Specific dates shown on the timeline presented in FIG. 7 are for illustrative purposes only.
- system 300 for predictive modeling of a biological incident for which sufficient historical information on incidence of the disease is not available, for example anthrax or pandemic flu events, is shown.
- system 300 may be implemented according to method S 200 as illustrated in FIG. 9 .
- biological incident descriptions 310 are defined. These descriptions 310 are used to generate a disease model 320 simulating outbreaks of varying virulence, transmissibility, and duration.
- An OLSC-DT Query Generator 330 is generated to simulate how infected persons with predicted symptoms would search that OLSC-DT. Simulated OLSC-DT queries 340 are subsequently defined. Baseline OLSC-DT Queries 350 are then added to simulated OLSC-DT queries 340 .
- Simulated and Baseline OLSC-DT Queries 340 , 350 and Biological Incident Descriptions 310 are used to create a Biological Incident Prediction Model 360 capable of predicting and charactering an outbreak based on OLSC-DT query data.
- System 300 may be validated by applying the Biological incident Prediction Model 360 to future OLSC-DT queries 370 to produce biological incident detection 380 , generating an alert when an outbreak is detected.
- a method S 200 for predicting the incidence of a disease or disorder starts at S 201 .
- OLSC-DT data is characterized for symptom patterns consistent with infectious diseases. This characterization may include normalization of the data.
- an infectious disease model is generated to simulate outbreaks of varying virulence, transmissibility, and duration.
- a OLSC-DT Query Generator is built.
- a biological incident prediction model is developed and optimized using the modified OLSC-DT datasets generated by the infectious disease model and OLSC-DT Query Generator.
- the outbreak/event prediction model is tested and validated.
- a prediction is generated based on new web-based symptom data.
- S 202 One purpose of S 202 is to characterize the number and nature of queries an individual who is experiencing influenza-like-illness (ILI) symptoms generates in the OLSC-DT. This information will serve as the basis for modeling how individuals with respiratory-type diseases interact with the OLSC-DT. To accomplish this objective, future incidence data, e.g. 2012-2013 influenza season and publicly available data from the CDC on incidence of ILI, may be utilized.
- ILI influenza-like-illness
- a dataset of OLSC-DT symptom queries from which the impact of seasonal influenza has been removed may be generated. Having this baseline dataset in which predicted OLSC-DT symptom queries from a biological incident can be overlaid is one step in the development of the biological incident detector prototype generated at S 208 .
- the model may be used to identify and remove queries in future OLSC-DT data, e.g., the 2012-2013 OLSC-DT data predicted to be generated by individuals experiencing the flu. The number of individuals experiencing the flu will may be determined based on published estimates from CDC.
- Disease models may be generated for diseases.
- the model could be a contagious or non-contagious disease of either intentional or natural origin, thus addressing the full spectrum of possible biological incidents.
- the model generated at S 204 will accommodate sensitivity analyses to allow for modeling a full range of potential outbreak characteristics, such as transmissibility, outbreak size, and virulence, which could be represented in the OLSC-DT dataset.
- the range of possible outbreak characteristics may first be defined. For example, outbreak size may be varied, as well as transmissibility of the disease. The goal is to identify which parameters of the disease models must be varied to determine the characteristics of an outbreak that will allow for accurate prediction. A list of parameters may be generated to drive the design of disease models.
- a number of open source influenza models have already been generated to predict disease spread, outbreak duration, and the number of people infected. Possible options include Community Flu 2.0, an Excel-based influenza model built by the CDC. Community Flu is an agent-based model that allows for tracking of infected individuals as they interact with the na ⁇ ve population. This open-source and publicly available model allows for modification of both inputs and parameters.
- An anthrax model may be developed, for example a model similar to that used for anthrax modeling in the Department of Homeland Security's Integrated CBRN Terrorism Risk Assessment (ITRA) to model the public health impact of the intentional exposure of individuals to anthrax by a terrorist or terrorist organization.
- ITRA Integrated CBRN Terrorism Risk Assessment
- Existing epidemiological models of disease spread would need to be modified to track the symptomology experienced by the ill, in order to utilize output from the model to generate queries in an internet-based symptom diagnostic tool.
- a further step in preparing the output of the outbreak simulations is to translate that output into a form compatible with the baseline OLSC-DT dataset.
- each simulation is suitably incorporated into the baseline OLSC-DT data as if it was generated by individuals making symptom checker queries.
- Each simulated dataset is bounded by location and number of individuals making queries.
- the specific algorithm that relates outbreak simulation output to specific patterns of symptom checker queries for influenza may be based in actual query data generated from early in the 2012-13 influenza outbreak.
- the algorithm for anthrax may be generated by expert judgment about the expected type and timing of early symptoms of inhalational anthrax based in the current medical literature and depending on the extensive information available from the October 2001 outbreak.
- the range of biological incident simulation studies that need to be performed may be designed. For example, if the scientific literature reveals that Ro for influenza can vary between 0.5 and 5, simulation studies may be run that include Ro values from 0.5 to 5, leading to variability in the number of people from simulation run to simulation run. Varying model parameters, such as transmissibility and virulence (and combinations thereof), according to published scientific literature may provide a scientifically rigorous and supported simulation of the full event space.
- a series of simulations may be run to characterize the full event space (potential different outbreak sizes, durations, intensities).
- Outputs from the simulation study suitably constitute the inputs for the development of system 300 .
- these outputs are be formatted as WebMD queries.
- System 300 may assess the probability of a biological incident in a geographically and temporally specific manner and characterize the incident based on OLSC-DT data.
- the characterization of the biological incident will include estimation of factors such as contagiousness, degree of transmissibility, and virulence.
- Machine learning and statistical analysis techniques may be used to develop optimal models for biological incident characteristics.
- system 300 may take as input OLSC-DT queries and produce daily, geographically specific predictions of the probability of a biological incident and important characteristics that allow forecasting of its size and intensity, transmissibility, causation (deliberate vs. natural), and its potential microbiologic causes.
- System 300 's performance in S 208 may be evaluated based on future data, e.g. 2013-2014 influenza season data.
- the 2013-4 OLSC-DT dataset may be obtained and analyzed using system 300 . Its output in terms of identifying the initial phases of the annual influenza event may be compared against other extant systems including the CDC's surveillance data and forecasts.
- Daily prediction maps of the probability of a biological incident in the next one to two weeks may be produced. In regions where the probability of an incident crosses a specific threshold, more in-depth predictions of the characteristics of the biological incident, such as transmissibility and virulence, may be produced.
- system 300 Based on the ability of the algorithm to detect the presence of an influenza outbreak in the 2013-2014 influenza season OLSC-DT query data, one can infer system 300 's performance in detecting an anthrax outbreak by looking at the outbreak parameters that allow for detection. For example, if system 300 detects influenza outbreaks that cause individuals to develop a fever greater than 100° F., then it is likely that it will also be able to detect patients suffering from anthrax.
- WebMD symptom counts were constructed. Each unique visitor within a postal code within HHS Region 3 who entered a particular symptom was counted. The significance of each symptom was assessed individually in a time series model according to FIG. 7 . Fourteen symptoms were considered: (1) Body aches or pains, (2) chills, (3) cough, (4) diarrhea, (5) difficulty breathing through nose, (6) fatigue, (7) fever, (8) headache, (9) headache (worst ever), (10) joint's ache, (11) nausea or vomiting, (12) runny nose, (13) shaking chills (rigors), (14) sore throat.
- PCA Principle component analysis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Veterinary Medicine (AREA)
- Business, Economics & Management (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Fluid Mechanics (AREA)
- Human Resources & Organizations (AREA)
- Primary Health Care (AREA)
- Tourism & Hospitality (AREA)
- Economics (AREA)
- Medical Informatics (AREA)
- Strategic Management (AREA)
- Epidemiology (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Marketing (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Child & Adolescent Psychology (AREA)
- Development Economics (AREA)
- Game Theory and Decision Science (AREA)
- Entrepreneurship & Innovation (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 14/767,820, filed Aug. 13, 2015, which is a national stage of PCT/US14/016411, filed Feb. 14, 2014, which claims the benefit of U.S. Provisional Application No. 61/765,564 filed Feb. 15, 2013. U.S. patent application Ser. No. 14/767,820 filed Aug. 13, 2015, PCT/US14/016411 filed Feb. 14, 2014, and Provisional Application No. 61/765,564 filed Feb. 15, 2013 are incorporated herein by reference in their entirety.
- The present disclosure relates to systems and methods for the early detection and characterization of outbreaks of infectious diseases or disorders. Generally, the system may be used for capturing and analyzing web-based patient symptom queries to thereby predict future changes in the incidence of infectious illness in both time and location. Methods to predict the incidence of disease or disorders are also disclosed.
- In public health practice, the earliest detection of a disease outbreak offers the best opportunity to mitigate its effects. Consequently, one of the core functions of public health surveillance is to monitor public health status and recognize at the earliest possible time, the appearance of disease or a change in its distribution or incidence. To address that need, various methods of early detection are incorporated throughout the public health infrastructure at all levels from local to national. Depending on the specific microbiological etiology of the outbreak, this early intervention allows for early recognition of affected individuals, initiation of treatment, and initiation of post-exposure mitigations among the exposed population. Accordingly, prediction technologies should offer the earliest reliable detection and characterization of outbreaks to afford the greatest opportunity to minimize causalities.
- Traditional systems of public health surveillance, developed and managed by public health agencies at various jurisdictional levels from local to national, fall into two categories: passive and active. Passive systems rely on reporting from community based healthcare personnel, whether from clinical encounters or laboratory identification of select microorganisms. These systems generally under-report infectious disease incidence and prevalence, and are only as timely as the reporters. Recognizing the limitations of the passive systems, public health surveillance authorities have developed active systems that prospectively monitor for the appearance of diseases and pathogens. These systems can identify the appearance of pathogens in the environment earlier than passive surveillance systems, but are limited still in their scope. However, they are also directed against specific agents and illnesses, and active systems that are based on environmental monitoring have their own inherent time delays between the appearance of a pathogen and its recognition in the surveillance system due to time delays for laboratory analysis.
- A substantial number of active surveillance systems have been developed. Some of these systems exploit search engines such as Google and Yahoo. The Internet, more specifically social media, is growing as a resource to gain advice or chat about health conditions. Microblogging sites like Twitter and Facebook or search engines such as Google collect random entries about conditions affecting its users.
- The best developed active surveillance system on the national scale is the CDC's system for influenza. It provides a clear picture of the emergence and development of the annual influenza epidemic, but its reports lag the actual changes in influenza incidence by about a week. The reason for the lag is that the system depends on the reporting of medical visits by specific sentinel medical practices, of individuals ill with symptoms compatible with influenza. It requires that individuals become ill enough to request an appointment and wait for that appointment to occur before there is the possibility of a report being generated.
- Recognizing the time delays inherent in surveillance systems based on the data generated by clinical visits and the critical importance of detecting the earliest possible evidence of an outbreak, there have been a number of methods proposed to accelerate reporting. Many of these are based on examining information from individuals who may be developing illness, eliminating the additional steps required to seek medical care and generate a medical report. All these techniques exploit one aspect or another of the public's use of the internet to report or obtain information. Others have used medical query sites maintained by hospitals or health departments, emergency rooms or pharmacy visits.
- In one embodiment, a system for predicting the incidence of a disease or disorder includes a web-based symptom checker for producing a structured dataset, a data analysis component for producing a multivariate dataset from the structured dataset, a principle component analysis component for producing a linear combination of orthogonal symbols representative of a disease or disorder, and a multivariate statistical model for predicting the incidence of disease or disorder using the symbols constructed from the principal component analysis.
- In another embodiment, a method for predicting the incidence of a disease or disorder includes producing a multivariate dataset representing internet symptom counts, performing principle component analysis on the multivariate dataset, creating a time series model using weekly illness incidence data and principal components of internet symptom data, and applying the time series model to new internet symptom data to predict the incidence of a disease or disorder.
- The following is a brief description of the drawings, which are presented for the purposes of illustrating the exemplary embodiments disclosed herein and not for the purposes of limiting the same.
-
FIG. 1 is an overview diagram of a system for predicting the incidence of a disease or disorder according to a first exemplary embodiment; -
FIG. 2 is a block flow diagram for a system for predicting the incidence of influenza like illness (ILI) according to a second exemplary embodiment; -
FIG. 3 is a method for predicting the incidence of a disease or disorder; -
FIG. 4 is an overview diagram of structured web-based symptom checker dataset; -
FIG. 5 is a diagram of Health and Human Services (HSS) Regions; -
FIG. 6 is a graph of CDC (Center of Disease Control) ILI Data for the 2009-2010 flu season for HSS Regions 3, 4, 5, and national; -
FIG. 7 is a timeline illustration of the time series modeling approach used in the system and methods ofFIGS. 1-3 ; -
FIG. 8 is a block flow diagram for a system for predicting the incidence of disease or disorder according to a third exemplary embodiment; -
FIG. 9 is a method for predicting the incidence of a disease or disorder according to a second exemplary embodiment; -
FIG. 10 is a table of principal component analysis (PCA) parameter estimates indicating the most statistically significant predictor components (PCs) for predicting CDC ILI counts using the system according to the second exemplary embodiment shown inFIG. 2 ; -
FIG. 11 is a graph of the prediction performance of the system according to the second exemplary embodiment shown inFIG. 2 in HHSRegion 3; -
FIG. 12 is a graph of the prediction validation of the system according to the second exemplary embodiment shown inFIG. 2 in HHSRegion 4; and -
FIG. 13 is a graph of the prediction validation of the system according to the second exemplary embodiment shown inFIG. 2 in HHSRegion 5; - These figures are merely schematic representations based on convenience and the ease of demonstrating the existing art and/or the present development, and are, therefore, not intended to indicate relative size and dimensions of the assemblies or components thereof.
- Although specific terms are used in the following description for the sake of clarity, these terms are intended to refer only to the particular structure of the embodiments selected for illustration in the drawings, and are not intended to define or limit the scope of the disclosure. In the drawings and the following description below, it is to be understood that like numeric designations refer to components of like function.
- Prediction systems for detecting the incidence of a disease or disorder according to the present disclosure may capture patient-based symptom queries to a public symptom search engine in its clinician-informed database of disease symptoms. This database may then be analyzed at or near real-time to detect changes in the incidence of inquiries related to infectious illness syndromes in terms of both time and location. At the end of the development process, the prediction system may be validated against real outbreak data in order to demonstrate its real-world performance.
- The systems and methods according to the following disclosure may include: 1) Evaluation of events in (near) real-time; 2) The ability to discriminate meaningful information from background noise with adequate sensitivity to provide useful early detection and; 3) The ability to provide geographical and temporal characteristics of an event (i.e., where it is centered, the likely extent, speed of spread, and the characteristics of illness that indicate specific causes).
- It is recognized herein that any major public system based on Internet usage has a limited window of maximum utility, which occurs very early and very briefly in an event. Once there is public knowledge of an outbreak, the parameters of public interaction change, and affect the ability of any analytic system based on evaluating internet data to reach reliable assessments of the important characteristics of the outbreak. It is precisely this early and limited window of patient queries that will allow a predictive system to accurately and reliably provide early warning and detection of an outbreak. Furthermore, the disclosed systems and methods may utilize a stronger dataset (e.g. structured, targeting medically relevant symptoms) than other public systems like Google, and will lead the ‘reliability race’ because of the sheer number and type of queries in a structured dataset, such as the data generated by on-line symptom checking diagnostic tools (OLSC-DT) like WebMD's Symptom Checker (at http://www.webmd.com/) or iTriage (https://www.itriagehealth.com/#!/avatar). Because data from OLSC-DT can be structured data already filtered to health-related data (rather than the world of search queries provided by Google) and because geo-location (using both IP and user-inputted zip codes) and time tags can be collected by OLSC-DT, predictive systems and methods using this dataset are expected to provide greater reliability in detection as compared with data mined from unstructured sources.
- With reference to
FIG. 1 , asystem 100 for predicting the incidence of a disease or disorder according to a first exemplary embodiment includes at least one third party side and a supervisor side. In one embodiment, there are a plurality of third party sides and one supervisor side. The number of third party sides depends on the number of users reporting symptoms of a disease or disorder to the symptom checker website. At the third party side, a third party user 104 (i.e., a person experiencing symptoms of illness and utilizing the symptoms checker website) inputs data into a third party user terminal 102 (e.g. a computer, tablet computer, or other device running a web browser connected with the symptoms checker website, although other terminal devices such as a dedicated “dumb” terminal are also contemplated). Theuser 104 views adisplay 106 attached to the terminal 102 so that a web-basedsymptom checker website 108 may be engaged by theuser 104. Theuser 104 inputs symptom specific data into thewebsite 108 using a dialog, preferably a graphical user interface (GUI) dialog, such as a web form presenting lists of symptoms and checkboxes via which the user identifies the symptoms present in the user. Some symptoms may be entered using other GUI dialogs which enable entry of quantitative data, e.g. body temperature as measured by an oral thermometer, body weight, et cetera. Other GUI dialogs are also contemplated. The resulting data are organized as a structured data set for theuser 104. In some illustrative embodiments, however, the specific user-symptom association is not maintained, but rather the data for the purpose of disease tracking are output as astructured symptom dataset 112 containingindividual user 104 symptom counts, each symptom count associated with a time stamp and geographical designation. This approach loses relevant information pertaining to co-occurrence of symptoms in a single user; however, it has advantages in enhanced data processing efficiency, reduced data storage requirements, and elimination of certain potential medical information privacy issues. Thestructured dataset 112 may include demographic information, such as the age, gender, and zip code of theuser 104. It may also include specific symptoms selected by theuser 104, body location, qualifiers or follow-up questions to symptoms, or possible conditions based on algorithms using symptom qualifiers. Thestructured dataset 112 is uploaded to aSQL symptom database 114 and stored on aserver 130. - On the supervisor side, a
supervisor 124 inputs data into apredictive model terminal 122. The supervisor views adisplay 126 attached to the terminal 122 so that an analysis/prediction interface 128 may be engaged by thesupervisor 124. The input provided by thesupervisor 124 at thepredictive model terminal 122 includes select database queries or other filters for creating subsets of data within aserver 130 using data from theSQL symptom database 114. The input may also include a time series lag setting, which is utilized by theserver 130 in creating time series models. - The
server 130 includes an input/output module 132 which receives input from the thirdparty user terminal 102 andpredictive model terminal 122, as well as past weekly (or other chosen time interval)illness incidence data 157 and newsymptom incidence data 159. Theillness incidence data 157, may be obtained by any reporter agency or sentinel provider that collects counts of symptom incidents associated with a disease or disorder. For example, in the United States the Centers for Disease Control (CDC) collects data associated with influence like illness (ILI). The CDC defines ILI by the symptoms of fever (equal to or greater than 100°) and cough and/or sore throat. The CDC collects its data from sentinel providers across the country. - The
exemplary server computer 130 may includemain memory 140 which storesinstructions 141 for implementing the exemplary method described with respect toFIG. 3 , and aprocessor 134, in communication with thememory 140, for executing theinstructions 141. 132, 134, 140, and 150 may communicate via a data/Hardware components control bus 136. - In an exemplary embodiment, the
main memory 140 stores adataset analysis component 142 for creating a multivariable dataset from data within theSQL symptom database 114. (While a SQL database is employed in the illustrative examples, other data storage/processing systems are also contemplated). Adataset filtering component 144 creates subsets within the multivariable dataset based on, e.g., physician advice as to the most important symptoms, or other inputs provided by thesupervisor 124 at thepredictive model terminal 122. (Alternatively, such feature selection may be “front-ended”, e.g. performed during construction of the structuredsymptom data set 112 by only storing the chosen subset of symptoms as the data set 112). APCA component 146 performs principal component analysis (PCA) on the subsets (or filtered multivariable dataset) to produce a linear combination of orthogonal variables. Other methods are contemplated for the construction of feature vectors from the structured symptom data set. A time series modeling component 148 creates a time series model. The time series model may be dependent upon the output of thePCA component 146 and weeklyillness incidence data 157. - The
exemplary server 130 also includes adata memory 150 which stores the most currenttime series model 152 calculated by the timeseries modeling component 152. The currenttime series model 152 is stored indata memory 150 to predict the incidence of new disease or disorder occurrences in a designated future (e.g. week-ahead) time interval based on thetime series model 152 applied to newsymptom incidence data 159 and historicweekly incidence data 157. - The
140, 150 may be separate or combined and may represent any type of non-transitory computer readable medium such as random access memory (RAM), read only memory (ROM), magnetic disk or tape, optical disk, flash memory, or holographic memory. In one embodiment, theserver computer memory 140, 150 comprises a combination of random access memory and read only memory. In some embodiments, thememory processor 134 andmemory 140 and/or 150 may be combined in a single chip. The input/output module 132 allows the computer to communicate with other devices via a computer network, such as a local area network (LAN) or wide area network (WAN), or the Internet, and may comprise a modulator/demodulator (MODEM), wired Ethernet, wireless WiFi, or so forth. - The
digital processor 134 can be variously embodied, such as by a single-core processor, a dual-core processor (or more generally by a multiple-core processor), a digital processor and cooperating math coprocessor, a digital controller, or the like. Thedigital processor 134, in addition to controlling the operation of theserver computer 130, executesinstructions 141 stored inmemory 140 for performing the method outlined inFIG. 3 . - The third
party user terminal 102 andpredictive model terminal 122 may be similarly configured to theserver computer 130 and may each comprise one or more specific or general purpose computing devices, such as a PC, such as a desktop, a laptop, palmtop computer, portable digital assistant (PDA), server computer, cellular telephone, tablet computer, pager, combination thereof, or other computing device capable of executing instructions for performing the client side operations of the exemplary method. The thirdparty user terminal 102 andpredictive model terminal 122 may have memory, a processor, and an input/output device for communicating with other devices via the network. The thirdparty user terminal 102 andpredictive model terminal 122 may also include an agent user input device, analogous to user input device, such as a keyboard, keypad, touchscreen, cursor control device, or combination thereof, or the like, for inputting commands to the respective processor. - The term “software,” as used herein, is intended to encompass any collection or set of instructions executable by a computer or other digital system so as to configure the computer or other digital system to perform the task that is the intent of the software. The term “software” as used herein is intended to encompass such instructions stored in storage medium such as RAM, a hard disk, optical disk, or so forth, and is also intended to encompass so-called “firmware” that is software stored on a ROM or so forth. Such software may be organized in various ways, and may include software components organized as libraries, Internet-based programs stored on a remote server or so forth, source code, interpretive code, object code, directly executable code, and so forth. It is contemplated that the software may invoke system-level code or calls to other software residing on a server or other location to perform certain functions.
- With reference to
FIGS. 2 and 3 , asystem 200 for predicting the incidence of a disease or disorder suitably implemented using hardware such as that described with reference toFIG. 1 uses OLSC-DT data 212. The OLSC-DT data has substantial advantages for disease occurrence tracking because users input their symptoms using a web form or other dialog specifically configured to elicit symptom information, obviating the need for text interpretation or other data mining operations, and decreasing the number of misleading queries. Many of these systems, such as WebMD's Symptom Checker are tied to health information services, which provide users with additional information on medical conditions and topics. These systems maintain customized portal, which walk users through a series of questions answered through the click of a button or selection from drop-down lists about the body location and specific symptoms with qualifying information such as intensity or character of pain. Based on the information entered, the user is directed to seek emergency care and/or shown a list of possible causes. Some of these systems, like the WebMD Symptom Checker, also collect additional parameters, such as gender, age, date, time, and geographical locations through zip code entry and user internet protocol (IP) address. Analysis of these data, which specifically utilizes queried symptoms, can look at changes in the incidence and frequencies of symptom queries and trends over time, and by location, for various conditions to determine if there are potential spikes in illnesses or disease conditions. - Preparation of the
system 200 includes the OLSC-DT data 212 being imported to aSQL database 214. Thedata 212 is then selected and counted by unique visitors by symptom and region bydataset analysis component 242. A region-specific weekly counts of symptom incidencemultivariable data set 243 is produced. Thedataset 243 is filtered into one or more subsets defined by subject matter expertise (SME, e.g. influenza-relevant symptoms identified by medical experts) by adataset filtering component 244. In the exemplary embodiment, 14 subsets are used representing 14 important symptoms for influenza like illness (ILI). - Development of the
system 200 includes the filtered dataset being used for principal component analysis (PCA) by aPCA component 246. Other feature construction methods, such as partial lease squares regression, are contemplated for constructing feature vectors. The output of thePCA component 246 may subsequently be used along with weekly CDCILI Incidence data 247 by a timeseries model component 248 to produce atime series model 248. The secondexemplary embodiment system 200 differs fromsystem 100 in that weekly illness incidence data is specifically obtained from the CDC and the symptom query data is subset to include only symptoms involved in influenza like illness (ILI). - Application of the
predictive system 200 includes applying thetime series model 248 to new specific weekly counts ofsymptoms incidence 259 to create a future prediction ofILI incidence 260. - With particular reference to
FIG. 3 , a method for predicting the incidence of a disease or disorder starts at S101. At S101, a dataset is uploaded into a SQL database. At S104, queries are generated to summarize-out patient symptom counts from visitors that queried individual symptoms. At S106, a multivariate dataset is produced representing patient symptom counts, time of queries, and/or geography, which may or may not include originating I.P. address. At S108, the multivariate dataset is subset based on, e.g. algorithms, manually input filters, expert medical device regarding the important predictive factors associated with the particular disease being predicted, ect. At S110, a principal component analysis or other multivariate feature construction algorithm is performed to create orthogonal variables that are linear combinations of input variables. At S112, a time series model is created using weekly illness incidence data. At S114, the time step lag in a time series model is adjusted based on the desired scope of prediction. At S116, the time series model is applied to new region specific data showing incidence of a disease or disorder to predict the incidence of a new disease or disorder. - The method of
FIG. 3 may be implemented on one or more general purpose computers, special purpose computer(s), a programmed microprocessor or microcontroller and peripheral integrated circuit elements, an ASIC or other integrated circuit, a digital signal processor, a hardwired electronic or logic circuit such as a discrete element circuit, a programmable logic device such as a PLD, PLA, FPGA, Graphical card CPU (GPU), or PAL, or the like, e.g. on the hardware described with reference toFIG. 1 . In general, the method illustrated inFIG. 3 may be implemented in a computer program product or products that may be executed on a computer. The computer program product may be a non-transitory computer-readable recoding medium on which a control program is recorded, such as a disk, hard drive, or the like configured for performing the method. Common forms of computer-readable media include, for example, floppy discs, flexible discs, hard disks, magnetic tape, or any other magnetic storage medium, CD-ROM, DVD, or any other optical medium, a RAM, a PROM, an EPROM, a FLASH-EPROM, or other memory chip or cartridge, or any other non-transitory medium from which a computer can read and use. The computer program product may be integral with theserver computer 130, (for example, an internal hard drive of RAM), or may be separate (for example, an external hard drive operatively connected with the server computer 130), or may be separate and accessed via a digital data network such as a local area network (LAN) or the Internet (for example, as a redundant array of inexpensive of independent disks (RAID) or other network server storage that is indirectly accessed by theserver computer 130, via a digital network). - Alternatively, the method may be implemented in transitory media as a transmittable carrier wave in which the control program is embodied as a data signal using transmission media, such as acoustic or light waves, such as those generated during radio wave and infrared communications, and the like.
- Various aspects of the method S100 will now be described in greater detail:
- With reference to
FIG. 4 , a structured dataset such as that collected by WebMD Symptom checker categorizes data into numerous categorizes, such as Query Information, Symptoms, Body Locations and Qualifers, and Conditions. A variable number of symptoms may be associated with each query; a variable number of body locations and qualifiers may be associated with each symptom; a variable number of conditions may be associated with each query. - A structured dataset such as the dataset described in
FIG. 4 is uploaded to a SQL server for further refinement by generated queries. Queries may reduce the dataset to, e.g., a specific number of predictive symptoms. - With reference to
FIG. 5 , weekly illness incidence data may be obtained from any reporter agency or sentinel provider that collects counts of symptom incidents associated with a disease or disorder. In one embodiment, CDC ILI Data is used. The CDC collects data associated with influence like illness (ILI) data from sentinel providers across the country and reports it according to regions defined by the Health and Human Services (HHS). The CDC specifically defines ILI by the symptoms of fever (equal to or greater than 100°) and cough and/or sore throat. Any number of HHS regions may be used in creating the time series model. - With reference to
FIG. 6 , the percent of visits for ILI reported data to the CDC representing regions 3-5 and national flu season 2009-2010 is shown. With cross reference toFIG. 5 ,region 3 corresponds to Delaware, District of Columbia, Md., Pennsylvania, Virginia, and West Virginia.Region 4 corresponds to Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee.Region 5 corresponds to Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin. - With reference to
FIG. 7 , a time series modeling approach includes modeling of differences to achieve near stationarity of time series data. Lagged differences of CDC ILI Count data, such as that represented inFIGS. 5-6 , are used in a time series modeling approach (Z variables with subscripts t-3 and t-4) in the equations illustrated inFIG. 7 . Symptom query features, such as those constructed by principal component analysis are used in the modeling approach (X variables with subscript t-2) in the equations illustrated inFIG. 7 . CDC ILI counts may be predicted up to two weeks ahead (represented by t, week predicted) according to the time series modeling approach. Specific dates shown on the timeline presented inFIG. 7 are for illustrative purposes only. - With reference to
FIG. 8 , asystem 300 for predictive modeling of a biological incident for which sufficient historical information on incidence of the disease is not available, for example anthrax or pandemic flu events, is shown. In one embodiment,system 300 may be implemented according to method S200 as illustrated inFIG. 9 . Initially,biological incident descriptions 310 are defined. Thesedescriptions 310 are used to generate adisease model 320 simulating outbreaks of varying virulence, transmissibility, and duration. An OLSC-DT Query Generator 330 is generated to simulate how infected persons with predicted symptoms would search that OLSC-DT. Simulated OLSC-DT queries 340 are subsequently defined. Baseline OLSC-DT Queries 350 are then added to simulated OLSC-DT queries 340. Simulated and Baseline OLSC- 340, 350 andDT Queries Biological Incident Descriptions 310 are used to create a BiologicalIncident Prediction Model 360 capable of predicting and charactering an outbreak based on OLSC-DT query data.System 300 may be validated by applying the Biologicalincident Prediction Model 360 to future OLSC-DT queries 370 to producebiological incident detection 380, generating an alert when an outbreak is detected. - With reference to
FIG. 9 , a method S200 for predicting the incidence of a disease or disorder starts at S201. At S202, OLSC-DT data is characterized for symptom patterns consistent with infectious diseases. This characterization may include normalization of the data. At S204, an infectious disease model is generated to simulate outbreaks of varying virulence, transmissibility, and duration. At S206, a OLSC-DT Query Generator is built. At S208, a biological incident prediction model is developed and optimized using the modified OLSC-DT datasets generated by the infectious disease model and OLSC-DT Query Generator. At S210, the outbreak/event prediction model is tested and validated. At S212, a prediction is generated based on new web-based symptom data. - Various aspects of the method S200 will now be described in greater detail:
- S202: OLSC-DT Data is Characterized for Symptom Patterns Consistent with Infectious Diseases
- One purpose of S202 is to characterize the number and nature of queries an individual who is experiencing influenza-like-illness (ILI) symptoms generates in the OLSC-DT. This information will serve as the basis for modeling how individuals with respiratory-type diseases interact with the OLSC-DT. To accomplish this objective, future incidence data, e.g. 2012-2013 influenza season and publicly available data from the CDC on incidence of ILI, may be utilized.
- Additionally, at S202, a dataset of OLSC-DT symptom queries from which the impact of seasonal influenza has been removed may be generated. Having this baseline dataset in which predicted OLSC-DT symptom queries from a biological incident can be overlaid is one step in the development of the biological incident detector prototype generated at S208.
- Because seasonal influenza is itself a biological incident, the impact of seasonal influenza within the OLSC-DT data is optionally removed before other biological incidents, including other incidents similar to influenza, are overlaid on the OLSC-DT data. The model may be used to identify and remove queries in future OLSC-DT data, e.g., the 2012-2013 OLSC-DT data predicted to be generated by individuals experiencing the flu. The number of individuals experiencing the flu will may be determined based on published estimates from CDC.
- Disease models may be generated for diseases. The model could be a contagious or non-contagious disease of either intentional or natural origin, thus addressing the full spectrum of possible biological incidents. The model generated at S204 will accommodate sensitivity analyses to allow for modeling a full range of potential outbreak characteristics, such as transmissibility, outbreak size, and virulence, which could be represented in the OLSC-DT dataset.
- In order for the disease models to faithfully represent the range of OLSC-DT queries that persons infected may generate based on outbreak size and disease severity, the range of possible outbreak characteristics may first be defined. For example, outbreak size may be varied, as well as transmissibility of the disease. The goal is to identify which parameters of the disease models must be varied to determine the characteristics of an outbreak that will allow for accurate prediction. A list of parameters may be generated to drive the design of disease models.
- A number of open source influenza models have already been generated to predict disease spread, outbreak duration, and the number of people infected. Possible options include Community Flu 2.0, an Excel-based influenza model built by the CDC. Community Flu is an agent-based model that allows for tracking of infected individuals as they interact with the naïve population. This open-source and publicly available model allows for modification of both inputs and parameters.
- An anthrax model may be developed, for example a model similar to that used for anthrax modeling in the Department of Homeland Security's Integrated CBRN Terrorism Risk Assessment (ITRA) to model the public health impact of the intentional exposure of individuals to anthrax by a terrorist or terrorist organization. Existing epidemiological models of disease spread would need to be modified to track the symptomology experienced by the ill, in order to utilize output from the model to generate queries in an internet-based symptom diagnostic tool.
- A further step in preparing the output of the outbreak simulations is to translate that output into a form compatible with the baseline OLSC-DT dataset. After translation, each simulation is suitably incorporated into the baseline OLSC-DT data as if it was generated by individuals making symptom checker queries. Each simulated dataset is bounded by location and number of individuals making queries.
- The specific algorithm that relates outbreak simulation output to specific patterns of symptom checker queries for influenza may be based in actual query data generated from early in the 2012-13 influenza outbreak. The algorithm for anthrax may be generated by expert judgment about the expected type and timing of early symptoms of inhalational anthrax based in the current medical literature and depending on the extensive information available from the October 2001 outbreak.
- Using information available in the literature on the possible value ranges of parameters defined in S204, the range of biological incident simulation studies that need to be performed may be designed. For example, if the scientific literature reveals that Ro for influenza can vary between 0.5 and 5, simulation studies may be run that include Ro values from 0.5 to 5, leading to variability in the number of people from simulation run to simulation run. Varying model parameters, such as transmissibility and virulence (and combinations thereof), according to published scientific literature may provide a scientifically rigorous and supported simulation of the full event space.
- Furthermore, a list of parameter values and parameter value combinations (e.g., high transmissibility and low virulence) that will drive the execution of the simulation studies may be generated.
- For each of the disease models built in S204, a series of simulations may be run to characterize the full event space (potential different outbreak sizes, durations, intensities). Outputs from the simulation study suitably constitute the inputs for the development of
system 300. In illustrative examples, these outputs are be formatted as WebMD queries. -
System 300 may assess the probability of a biological incident in a geographically and temporally specific manner and characterize the incident based on OLSC-DT data. The characterization of the biological incident will include estimation of factors such as contagiousness, degree of transmissibility, and virulence. Machine learning and statistical analysis techniques may be used to develop optimal models for biological incident characteristics. At the completion of this task,system 300 may take as input OLSC-DT queries and produce daily, geographically specific predictions of the probability of a biological incident and important characteristics that allow forecasting of its size and intensity, transmissibility, causation (deliberate vs. natural), and its potential microbiologic causes. -
System 300's performance in S208 may be evaluated based on future data, e.g. 2013-2014 influenza season data. The 2013-4 OLSC-DT dataset may be obtained and analyzed usingsystem 300. Its output in terms of identifying the initial phases of the annual influenza event may be compared against other extant systems including the CDC's surveillance data and forecasts. - Using the 2013-2014 influenza season OLSC-DT query data, one may determine the capability of
system 300 to recognize and characterize the influenza outbreak. Daily prediction maps of the probability of a biological incident in the next one to two weeks may be produced. In regions where the probability of an incident crosses a specific threshold, more in-depth predictions of the characteristics of the biological incident, such as transmissibility and virulence, may be produced. - Based on the ability of the algorithm to detect the presence of an influenza outbreak in the 2013-2014 influenza season OLSC-DT query data, one can infer
system 300's performance in detecting an anthrax outbreak by looking at the outbreak parameters that allow for detection. For example, ifsystem 300 detects influenza outbreaks that cause individuals to develop a fever greater than 100° F., then it is likely that it will also be able to detect patients suffering from anthrax. - With reference to
FIGS. 10-14 , WebMD symptom counts were constructed. Each unique visitor within a postal code withinHHS Region 3 who entered a particular symptom was counted. The significance of each symptom was assessed individually in a time series model according toFIG. 7 . Fourteen symptoms were considered: (1) Body aches or pains, (2) chills, (3) cough, (4) diarrhea, (5) difficulty breathing through nose, (6) fatigue, (7) fever, (8) headache, (9) headache (worst ever), (10) joint's ache, (11) nausea or vomiting, (12) runny nose, (13) shaking chills (rigors), (14) sore throat. - Principle component analysis (PCA) was performed on the symptom counts identified as possible predictors of CDC ILI counts listed above. With reference to
FIG. 10 , the 1st, 2nd, 4th, and 9th PCs were statistically significant predictors of CDC ILI counts. R2=0.51 (without WebMD data, R2=0.02). - With reference to
FIGS. 11-13 , a percent of variability explained (PVE) metric was constructed to measure the predictive ability of the model according to EQN 1: -
- This metric was compared with Google Flu Trend's mean reported correlation of 0.90 for weekly data. In
FIG. 11 , prediction of performance inregion 3 is shown. Use of WebMD data shows an increase from 68.75% to 90.91% variance explained as calculated by EQN. 1. - With reference to
FIG. 12 , prediction of performance inregion 4 is shown. A PVE value of 92.98% variance explained was obtained. - With reference to
FIG. 13 , prediction of performance inregion 5 is shown. A PVE value of 92.61% variance explained was obtained. - It will be appreciated that various of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. It will be further appreciated that various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art which are also intended to be encompassed by the following claims.
Claims (28)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/523,238 US20190355082A1 (en) | 2013-02-15 | 2019-07-26 | Use of web-based symptom checker data to predict incidence of a disease or disorder |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361765464P | 2013-02-15 | 2013-02-15 | |
| PCT/US2014/016411 WO2014127204A2 (en) | 2013-02-15 | 2014-02-14 | Use of web-based symptom checker data to predict incidence of a disease or disorder |
| US201514767820A | 2015-08-13 | 2015-08-13 | |
| US16/523,238 US20190355082A1 (en) | 2013-02-15 | 2019-07-26 | Use of web-based symptom checker data to predict incidence of a disease or disorder |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2014/016411 Continuation WO2014127204A2 (en) | 2013-02-15 | 2014-02-14 | Use of web-based symptom checker data to predict incidence of a disease or disorder |
| US14/767,820 Continuation US10430904B2 (en) | 2013-02-15 | 2014-02-14 | Use of web-based symptom checker data to predict incidence of a disease or disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20190355082A1 true US20190355082A1 (en) | 2019-11-21 |
Family
ID=51354566
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/768,189 Active 2035-01-26 US10420886B2 (en) | 2013-02-15 | 2014-02-14 | Multi-flow universal tubing set |
| US16/523,238 Abandoned US20190355082A1 (en) | 2013-02-15 | 2019-07-26 | Use of web-based symptom checker data to predict incidence of a disease or disorder |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/768,189 Active 2035-01-26 US10420886B2 (en) | 2013-02-15 | 2014-02-14 | Multi-flow universal tubing set |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10420886B2 (en) |
| EP (1) | EP2956190A4 (en) |
| CA (1) | CA2901012C (en) |
| WO (1) | WO2014127209A1 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200244716A1 (en) * | 2017-08-28 | 2020-07-30 | Banjo, Inc. | Event detection from signal data removing private information |
| US10977097B2 (en) | 2018-04-13 | 2021-04-13 | Banjo, Inc. | Notifying entities of relevant events |
| US11122100B2 (en) | 2017-08-28 | 2021-09-14 | Banjo, Inc. | Detecting events from ingested data |
| US11315679B2 (en) | 2021-05-12 | 2022-04-26 | Cigna Intellectual Property, Inc. | Systems and methods for prediction based care recommendations |
| US20220335045A1 (en) * | 2021-04-20 | 2022-10-20 | International Business Machines Corporation | Composite event estimation through temporal logic |
| US11494439B2 (en) * | 2020-05-01 | 2022-11-08 | International Business Machines Corporation | Digital modeling and prediction for spreading digital data |
| WO2022261007A1 (en) * | 2021-06-08 | 2022-12-15 | Chan Zuckerberg Biohub, Inc. | Disease management system |
| US11587063B1 (en) * | 2016-07-06 | 2023-02-21 | United Services Automobile Association (Usaa) | Automated proximity fraud account lock systems and methods |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10709839B2 (en) | 2015-03-04 | 2020-07-14 | Repro-Med Systems, Inc. | Precision variable flow rate infusion system and method |
| US10500389B2 (en) * | 2016-01-04 | 2019-12-10 | Repro-Med Systems, Inc. | System and method for flared luer connector for medical tubing |
| EP4585228A3 (en) | 2017-04-07 | 2025-10-15 | Apellis Pharmaceuticals, Inc. | Dosing regimens and related compositions and methods |
| US20190201620A1 (en) | 2017-12-29 | 2019-07-04 | Repro-Med Systems, Inc. | High flow at low pressure infusion system and method |
| DE102018216508A1 (en) * | 2018-09-26 | 2020-03-26 | B. Braun Melsungen Ag | Kit for the modular design of a medical pump device and medical pump device |
| BR112022005035A2 (en) | 2019-09-19 | 2022-07-05 | Innovative Health Sciences Llc | SYSTEMS AND METHODS FOR PRECISE AND COMBINED IMMUNOGLOBULIN INFUSION |
| US20220370714A1 (en) * | 2019-09-19 | 2022-11-24 | Innovative Health Sciences, Llc | Tissue saturation responsive rapid automatically variable flow rate infusion system |
| US11278669B2 (en) | 2020-01-21 | 2022-03-22 | Repro Med Systems, Inc. | Gear-driven infusion assemblies, systems, and methods |
| US20230091531A1 (en) * | 2020-02-28 | 2023-03-23 | C. R. Bard, Inc. | Segmented Drainage Tubes |
| US11980736B2 (en) * | 2020-05-26 | 2024-05-14 | Carefusion 202, Inc. | Infusion pump flow rate control |
| JP2024529968A (en) * | 2021-07-28 | 2024-08-14 | エスエイチエル・メディカル・アーゲー | Apparatus and method for large volume drug administration - Patents.com |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1130161A (en) * | 1978-08-30 | 1982-08-24 | Herbert Mittleman | Drip chamber with backflow ball valve |
| US4424056A (en) * | 1981-11-27 | 1984-01-03 | Alza Corporation | Parenteral administration |
| US4681559A (en) * | 1985-12-23 | 1987-07-21 | Cordis Corporation | Plural valve three stage pressure relief system |
| US4723947A (en) * | 1986-04-09 | 1988-02-09 | Pacesetter Infusion, Ltd. | Insulin compatible infusion set |
| US4802650A (en) * | 1987-06-29 | 1989-02-07 | Abiomed, Inc. | Intravenous drug mixing and flow device |
| US4863429A (en) * | 1987-06-30 | 1989-09-05 | Baldwin Brian E | Syringe driver/syringe/tube connecting set fluid delivery arrangement, and tube connecting sets therefor |
| US6358239B1 (en) * | 1992-01-24 | 2002-03-19 | I-Flow Corporation | Platen pump |
| JPH07509A (en) * | 1992-07-31 | 1995-01-06 | Nissho Corp | Chemical injection device |
| US5318515A (en) * | 1992-08-17 | 1994-06-07 | Wilk Peter J | Intravenous flow regulator device and associated method |
| US5356379A (en) * | 1993-08-03 | 1994-10-18 | Vaillancourt Vincent L | Disposable ambulatory infusion pump assembly |
| US5549550A (en) * | 1995-01-13 | 1996-08-27 | Abbott Laboratories | Method of adding marker dye to nutritional product during enteral tube feeding |
| EP0874659A4 (en) * | 1995-12-04 | 1999-12-08 | Alphamed Inc | Infusion pump with disposable tubing and size indicating means |
| JP3266901B2 (en) * | 1996-07-17 | 2002-03-18 | ニプロ株式会社 | Multi-stage flow switching device |
| US5910135A (en) * | 1997-03-31 | 1999-06-08 | Innovative Design Associates | Intravenous infusion system |
| US5921965A (en) * | 1997-07-07 | 1999-07-13 | New York University | Tubing device for antibiotic administration through central venous catheters |
| US6074366A (en) * | 1998-01-16 | 2000-06-13 | Tandem Medical Inc. | Medication delivery apparatus |
| US6095491A (en) * | 1998-10-02 | 2000-08-01 | Science Incorporated | In-line flow rate control device |
| US6398765B1 (en) * | 1999-03-01 | 2002-06-04 | Pro Duct Health, Inc. | Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts |
| US6471675B1 (en) * | 1999-04-30 | 2002-10-29 | Medtronic, Inc. | Passive flow control devices for implantable pumps |
| US6645183B2 (en) * | 1999-09-22 | 2003-11-11 | Advanced Infusion, Inc. | Catheter with adjustable flow rate |
| US6669668B1 (en) * | 1999-11-05 | 2003-12-30 | Tandem Medical | Medication delivery pump |
| TW483233B (en) * | 2000-05-30 | 2002-04-11 | Alps Electric Co Ltd | Electronic circuit unit |
| JP2002077544A (en) * | 2000-08-28 | 2002-03-15 | Nikon Corp | Image reading apparatus, storage medium storing control procedure thereof, and data structure for encoding and transmitting a computer program signal including the control procedure |
| ES2173042B1 (en) * | 2001-02-28 | 2003-06-16 | Lucas Victor Grifols | DEVICE AND PROCEDURE FOR FLOW CONTROL FOR MEDICINAL PRODUCTS. |
| WO2003006101A2 (en) * | 2001-07-10 | 2003-01-23 | Medrad, Inc. | Devices, systems and method for infusion of fluids |
| US6926706B1 (en) * | 2002-07-19 | 2005-08-09 | Repro-Med Systems, Inc. | Mechanical variable rate flow control for a constant pressure IV delivery system |
| US6957655B2 (en) * | 2002-09-20 | 2005-10-25 | Advanced Neuromodulation Systems, Inc. | Apparatus for dosage control |
| US6770057B2 (en) * | 2002-10-31 | 2004-08-03 | Hewlett-Packard Development Company, L.P. | Quick flow control for flexible tubing |
| US20060100578A1 (en) * | 2004-09-13 | 2006-05-11 | Tandem Medical, Inc. | Medication delivery apparatus and methods for intravenous infusions |
| US20070173786A1 (en) * | 2006-01-25 | 2007-07-26 | Angiodynamics, Inc. | Fluid injection system and method using multi-lumen catheters |
| GB0625896D0 (en) * | 2006-12-23 | 2007-02-07 | Colormatrix Holdings Inc | Apparatus for delivering a fluid and methods relating thereto |
| ITVR20070075A1 (en) * | 2007-05-29 | 2008-11-30 | Haemotronic Advanced Medical T | CLOSED CIRCUIT EXTRACTION SYSTEM FOR MANUAL ACTIVATION AND METHOD OF USE. |
| CN201085823Y (en) | 2007-07-10 | 2008-07-16 | 沈莉 | Disposal self-control analgesia pump |
| CN201139832Y (en) | 2008-01-11 | 2008-10-29 | 平湖乙儿山医疗器械有限公司 | Multi-pipeline chemotherapy infusion pump |
| JP5145177B2 (en) * | 2008-09-12 | 2013-02-13 | 株式会社K&Y | Infusion pump system |
| US20110097229A1 (en) * | 2009-10-09 | 2011-04-28 | Cauley Iii Thomas Henry | Feedback Controlled Syringe Pump |
| EP2359886A1 (en) * | 2010-02-12 | 2011-08-24 | Debiotech S.A. | Micromechanic passive flow regulator |
| US20120259291A1 (en) * | 2011-04-06 | 2012-10-11 | Navilyst Medical, Inc. | Medical flow device for multi-lumen catheters |
| EP2510960B1 (en) * | 2011-04-12 | 2017-06-28 | F. Hoffmann-La Roche AG | Infusion pump device with cylinder-piston dosing unit and optical piston position detection |
| US20140303559A1 (en) * | 2013-04-05 | 2014-10-09 | William Marsh Rice University | Automatic syringe pumps for drug and fluid delivery |
| CN103252005A (en) | 2013-04-10 | 2013-08-21 | 湖南平安医械科技有限公司 | Medical quantifying device for transfusion |
| US10709839B2 (en) * | 2015-03-04 | 2020-07-14 | Repro-Med Systems, Inc. | Precision variable flow rate infusion system and method |
-
2014
- 2014-02-14 CA CA2901012A patent/CA2901012C/en active Active
- 2014-02-14 WO PCT/US2014/016426 patent/WO2014127209A1/en not_active Ceased
- 2014-02-14 US US14/768,189 patent/US10420886B2/en active Active
- 2014-02-14 EP EP14752195.9A patent/EP2956190A4/en not_active Withdrawn
-
2019
- 2019-07-26 US US16/523,238 patent/US20190355082A1/en not_active Abandoned
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11587063B1 (en) * | 2016-07-06 | 2023-02-21 | United Services Automobile Association (Usaa) | Automated proximity fraud account lock systems and methods |
| US11893568B1 (en) * | 2016-07-06 | 2024-02-06 | United Services Automobile Association (Usaa) | Automated proximity fraud account lock systems and methods |
| US20200244716A1 (en) * | 2017-08-28 | 2020-07-30 | Banjo, Inc. | Event detection from signal data removing private information |
| US11025693B2 (en) * | 2017-08-28 | 2021-06-01 | Banjo, Inc. | Event detection from signal data removing private information |
| US11122100B2 (en) | 2017-08-28 | 2021-09-14 | Banjo, Inc. | Detecting events from ingested data |
| US10977097B2 (en) | 2018-04-13 | 2021-04-13 | Banjo, Inc. | Notifying entities of relevant events |
| US11494439B2 (en) * | 2020-05-01 | 2022-11-08 | International Business Machines Corporation | Digital modeling and prediction for spreading digital data |
| US20220335045A1 (en) * | 2021-04-20 | 2022-10-20 | International Business Machines Corporation | Composite event estimation through temporal logic |
| US12436964B2 (en) * | 2021-04-20 | 2025-10-07 | International Business Machines Corporation | Composite event estimation through temporal logic |
| US11315679B2 (en) | 2021-05-12 | 2022-04-26 | Cigna Intellectual Property, Inc. | Systems and methods for prediction based care recommendations |
| US11688513B2 (en) | 2021-05-12 | 2023-06-27 | Cigna Intellectual Property, Inc. | Systems and methods for prediction based care recommendations |
| WO2022261007A1 (en) * | 2021-06-08 | 2022-12-15 | Chan Zuckerberg Biohub, Inc. | Disease management system |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014127209A1 (en) | 2014-08-21 |
| US20150374911A1 (en) | 2015-12-31 |
| EP2956190A4 (en) | 2016-08-24 |
| EP2956190A1 (en) | 2015-12-23 |
| CA2901012A1 (en) | 2014-08-21 |
| US10420886B2 (en) | 2019-09-24 |
| CA2901012C (en) | 2021-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190355082A1 (en) | Use of web-based symptom checker data to predict incidence of a disease or disorder | |
| US10430904B2 (en) | Use of web-based symptom checker data to predict incidence of a disease or disorder | |
| US10332637B2 (en) | Use of web-based symptom checker data to predict incidence of a disease or disorder | |
| Shapiro et al. | Characterizing COVID-19 and influenza illnesses in the real world via person-generated health data | |
| JP7471354B2 (en) | Preemptive asthma risk notification based on drug-device monitoring | |
| JP7565800B2 (en) | Preemptive asthma risk notification based on drug-device monitoring | |
| Danon et al. | Social encounter networks: characterizing Great Britain | |
| US8788291B2 (en) | System and method for estimation of missing data in a multivariate longitudinal setup | |
| Howick et al. | Evaluating intervention strategies in controlling coronavirus disease 2019 (COVID-19) spread in care homes: An agent-based model | |
| US20160063210A1 (en) | Systems and methods for administering health care systems | |
| Mavragani et al. | Forecasting AIDS prevalence in the United States using online search traffic data | |
| Mavragani et al. | Integrating smart health in the us health care system: infodemiology study of asthma monitoring in the google era | |
| Khasha et al. | Mobile GIS-based monitoring asthma attacks based on environmental factors | |
| Baltrusaitis et al. | Differences in regional patterns of influenza activity across surveillance systems in the United States: comparative evaluation | |
| Fan et al. | Accurate forecasting of emergency department arrivals with internet search index and machine learning models: Model development and performance evaluation | |
| Luo et al. | Using temporal features to provide data-driven clinical early warnings for chronic obstructive pulmonary disease and asthma care management: protocol for a secondary analysis | |
| Briesacher et al. | Did Medicare Part D affect national trends in health outcomes or hospitalizations? A time-series analysis | |
| Cheng et al. | Structural models used in real-time biosurveillance outbreak detection and outbreak curve isolation from noisy background morbidity levels | |
| Lin et al. | Progress in understanding human-COVID-19 dynamics using geospatial big data: a systematic review | |
| Jacquez | Spatial clustering and autocorrelation in health events | |
| Chang et al. | A global study of screening intensity and economic status on epidemic control performance during various epidemic periods of COVID‐19 mutant strains | |
| Ruuls | Pediatric Respiratory Exacerbation Detection: Innovating Asthma Care with Artificial Intelligence (PREDICTA): An AI Model to predict pediatric asthma exacerbations and personalized risk factors | |
| Pavlin | Syndromic surveillance for infectious diseases | |
| Ibrahim | Forecasting patient demand and predicting inpatient admission via machine learning techniques in acute care domain | |
| Lin et al. | Understanding Human-COVID-19 Dynamics using Geospatial Big Data: A Systematic Literature Review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: BATTELLE MEMORIAL INSTITUTE, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCMILLAN, NANCY J.;FENG, JINGYU;STAMPS, KATHRYN;AND OTHERS;SIGNING DATES FROM 20140311 TO 20140321;REEL/FRAME:049871/0838 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
| STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
| STCV | Information on status: appeal procedure |
Free format text: APPEAL BRIEF (OR SUPPLEMENTAL BRIEF) ENTERED AND FORWARDED TO EXAMINER |
|
| STCV | Information on status: appeal procedure |
Free format text: EXAMINER'S ANSWER TO APPEAL BRIEF MAILED |
|
| STCV | Information on status: appeal procedure |
Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS |
|
| STCV | Information on status: appeal procedure |
Free format text: BOARD OF APPEALS DECISION RENDERED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |